Noninvasive Liver Fibrosis Markers in the Evaluation of Fibrosis Regression After Direct-Acting Antiviral Therapy

J Infect Dis. 2024 Jun 14;229(6):1926-1927. doi: 10.1093/infdis/jiae095.
No abstract available

Publication types

  • Letter
  • Research Support, Non-U.S. Gov't

MeSH terms

  • Adult
  • Antiviral Agents* / therapeutic use
  • Biomarkers* / blood
  • Female
  • Hepatitis C, Chronic / drug therapy
  • Humans
  • Liver / pathology
  • Liver Cirrhosis* / drug therapy
  • Liver Cirrhosis* / virology
  • Male
  • Middle Aged

Substances

  • Antiviral Agents
  • Biomarkers